Menu Menu

AMRX    Amneal Pharmaceuticals Inc    1723128    
Income Statement
Revenue amrx-20240930 702,468,000
Net Income amrx-20240930 -156,000
Profit Margin -0.02%

Balance Sheet
Current Assets 1,513,294,000
Assets 3,460,978,000
Current Liabilities 1,095,209,000
Liabilities 3,554,545,000
Equity -93,567,000

Cash Flow Statement
Operating Cash Flow 177,021,000
Investing Cash Flow -46,937,000

Market Analysis
Price 8.26
BVPS 21.21
PB 0.39
PS 2.54
FCF 130,084,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/01 0.54
Apr May Jun
5/03 0.14
Jul Aug Sep
8/09 0.16
Oct Nov Dec
11/08

Find a discrepancy? The most accurate way to find company fundamental data is to view AMRX documents filed with the SEC.


AMRX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas